Skip to main content

and
  1. No Access

    Article

    Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence

    This study aimed to assess whether postoperative adjuvant chemoimmunotherapy could lead to better clinical outcomes for high-risk patients with perihilar cholangiocarcinoma (pCCA).

    Qin-qin Liu, **ang-de Shi, Yan-fang Ye, Qi-bin Tang in Cancer Immunology, Immunotherapy (2023)